Drug Topics

APRIL 20, 2025

From 1990 to 2021, researchers explored the global burden of atopic dermatitis among older adults.

459

459

Pharma Marketing Network

APRIL 20, 2025

Introduction In todays fast-evolving healthcare environment, one truth has become increasingly clear: Healthcare Branding is no longer just about recognition; it’s about trust, authenticity, and relevance. As the healthcare sector shifts under the weight of new technologies, regulatory changes, and consumer demands, branding strategies that worked a decade ago are becoming obsolete.

Communication 59

Communication Customer Service 59

Pharmacy Times

APRIL 20, 2025

Philip Kuball, MD, neurology resident at NYU Langone Health, highlights the integral role of pharmacists in monitoring patient eligibility, managing dosing schedules, and ensuring safe medication interactions for lecanemab treatment in Alzheimer disease.

65

65

Pharma Marketing Network

APRIL 20, 2025

Introduction Is Big Pharma a villainous label or a misunderstood brand? In todays complex healthcare ecosystem, the term Big Pharma has become both a cultural catchphrase and a marketing dilemma. While the pharmaceutical industry continues to drive innovation, the public perception often skews negative. For marketers in 2025, understanding the implications of this term is more important than ever.

Labelling 52

Labelling Communication 52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

The Guardian - Pharmaceutical Industry

APRIL 20, 2025

The 176-year-old chemist is preparing for another change of hands. Whats the mood of staff and residents at its home base in Nottinghamshire? Weve had several rounds of cost-cutting and it could happen again, says a Boots worker. Fears are running high as the Nottinghamshire-based chemist prepares to change hands perhaps twice in quick succession. The US private equity firm Sycamore Partners is close to finalising a $10bn (7.8bn) deal to take over the listed US owner of Boots , Walgreens Boots

82

82

Pharma Marketing Network

APRIL 20, 2025

The question of Survival Rates for AIDS remains one of the most pressing concerns for patients, families, and clinicians alike. While AIDS was once synonymous with a death sentence, the narrative in 2025 tells a different storyone of progress, persistence, and possibility. But what do the numbers say today? And how does modern medicine impact outcomes?

Immunization 52

Immunization 52

The FDA Law Blog

APRIL 20, 2025

By Dr. Naomi Lowy, Principal Drug Regulatory Expert & James E. Valentine There is much change happening at FDA. In the wake of the April 1 st reduction in force, there has been a great deal of uncertainty about what the impacts will be. This rings particularly true amongst the rare disease patient community, along with many small biotech companies (and their investors) that take on the risk of developing orphan drugs for exceedingly small patient populations.

FDA 89

FDA 89